Cite
HARVARD Citation
Ailawadhi, S. et al. (2017). Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib. Therapeutic advances in hematology. pp. 3-12. [Online].